Home » Clinical Trials » Search Clinical Trials
Last updated on March 2020
The primary objective of this study is to establish a safe and effective dosing regimen of idelalisib in participants with relapsed or refractory follicular lymphoma (FL) who have no other therapeutic options.
Clinical Study Identifier: NCT02536300
Find a site near you
Subject: I'm Interested in Participating in Your Clinical Trial
Message: Dear Investigator,
Comment:
Thanks,
Recruitment Status: Open
Brief Description Eligibility Contact Research Team
Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up now »
Powered by
